Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source

Global drug maker Pfizer and biotech firm Amgen, each valued at over HK$1 trillion (US$153 billion), are among 22 strategic enterprises planning to open or expand offices in Hong Kong, the South China Morning Post has learned. A source said on Monday that these industry leaders were among companies from the fintech, cloud computing and aerial transport sectors set to sign agreements with the Office for Attracting Strategic Enterprises. The move will mark the sixth cohort under the government’s...


3 d.
Technology
ID: -8343383054014791572


Similar News expand_more


Technology
Technology
Technology
Technology
Technology
Economics
Technology
Economics
Technology
Economics
Politics
Technology
Technology
Technology
Economics
Economics
Economics
Travel
Technology
Technology
Economics
Technology
Technology
Economics
Economics
Economics
Technology
Economics
Politics
Economics
Economics
Technology
Economics
Technology
Technology
Travel
Technology
Economics
Economics
Economics
Technology
Automotive
Technology
Economics
Politics
Economics
Technology
Technology
Economics
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down